Cornerstone Planning Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.98K | Buy |
14
+4
| +40% | +$2.28K | ﹤0.01% | 611 |
|
|
2025
Q1 | $5.88K | Buy |
10
+4
| +67% | +$2.35K | ﹤0.01% | 690 |
|
|
2024
Q4 | $4.11K | Buy |
6
+2
| +50% | +$1.37K | ﹤0.01% | 621 |
|
|
2024
Q3 | $3.71K | Buy |
4
+1
| +33% | +$927 | ﹤0.01% | 638 |
|
|
2024
Q2 | $3.21K | Buy |
3
+2
| +200% | +$2.14K | ﹤0.01% | 661 |
|
|
2024
Q1 | $957 | Hold |
1
| – | – | ﹤0.01% | 792 |
|
|
2023
Q4 | $878 | Hold |
1
| – | – | ﹤0.01% | 732 |
|
|
2023
Q3 | $823 | Buy |
+1
| New | +$823 | ﹤0.01% | 827 |
|